摘要
神经退行性疾病(NDD)如阿尔茨海默病,帕金森氏病和亨廷顿氏病是一组异质性疾病,伴有神经元的进行性和严重性丧失。对于这些疾病没有完全的证据治疗,只有可以减轻某些症状的药物。为NDD开发有效的治疗方法是一项艰巨但必要的任务。因此,调查适用于许多NDD的目标的单萜类化合物具有高度相关性。许多单萜类化合物已经证明了由各种系统介导的有希望的神经保护活性。它可以形成制剂的基础,这对于减轻NDD症状和治疗疾病进展以及预防神经变性都是有用的。需要进一步开发包括检测具有高神经保护或神经营养活性的单萜类化合物及其衍生物以及合格临床试验的结果,以得出关于这些药物功效的可靠结论。
关键词: 乙酰胆碱酯酶抑制剂,阿尔茨海默病,大麻素,亨廷顿病,单萜,单萜类,神经保护活性,帕金森病。
Current Medicinal Chemistry
Title:Application of Monoterpenoids and their Derivatives for Treatment of Neurodegenerative Disorders
Volume: 25 Issue: 39
关键词: 乙酰胆碱酯酶抑制剂,阿尔茨海默病,大麻素,亨廷顿病,单萜,单萜类,神经保护活性,帕金森病。
摘要: Neurodegenerative disorders (NDDs) like Alzheimer's disease, Parkinson’s disease and Huntington’s disease are a heterogeneous group of disorders with the progressive and severe loss of neurons. There are no full proof cures for these diseases, and only medicines are available that can alleviate some of the symptoms. Developing effective treatments for the NDDs is a difficult but necessary task. Hence, the investigation of monoterpenoids which modulate targets applicable to many NDDs is highly relevant. Many monoterpenoids have demonstrated promising neuroprotective activity mediated by various systems. It can form the basis for elaboration of agents which will be useful both for the alleviation of symptoms of NDDs and for the treatment of diseases progression and also for prevention of neurodegeneration. The further developments including detections of monoterpenoids and their derivatives with high neuroprotective or neurotrophic activity as well as the results of qualified clinical trials are needed to draw solid conclusions regarding the efficacy of these agents.
Export Options
About this article
Cite this article as:
Application of Monoterpenoids and their Derivatives for Treatment of Neurodegenerative Disorders, Current Medicinal Chemistry 2018; 25 (39) . https://dx.doi.org/10.2174/0929867324666170112101837
DOI https://dx.doi.org/10.2174/0929867324666170112101837 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Discovery and Development of Drug Combinations for the Treatment of Various Diseases from Patent Literature (1980-Present)
Current Topics in Medicinal Chemistry Catalpol: A Potential Therapeutic for Neurodegenerative Diseases
Current Medicinal Chemistry Activity-dependent Synaptic Plasticity and Metaplasticity in Spinal Motor Networks
Current Pharmaceutical Design Neuropathic Pain and Lung Delivery of Nanoparticulate Drugs: An Emerging Novel Therapeutic Strategy
CNS & Neurological Disorders - Drug Targets Nanotubes at Neural and Immune Synapses
Current Medicinal Chemistry Neuroinflammation: A Therapeutic Target of Cotinine for the Treatment of Psychiatric Disorders?
Current Pharmaceutical Design Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders
Current Neuropharmacology Coenzyme Q10 and Neurological Diseases: An Update
Letters in Drug Design & Discovery Prospects for Discovering the Secondary Metabolites of <i>Cordyceps</i> Sensu Lato by the Integrated Strategy
Medicinal Chemistry The Role of Components of the Lymphoreticular System in Transmissible Spongiform Encephalopathy Pathogenesis and Neuroinvasion
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents The Vascular Component of Alzheimer`s Disease
Current Neurovascular Research Somatostatin and Cognitive Function in Neurodegenerative Disorders
Mini-Reviews in Medicinal Chemistry Ongoing Electroencephalographic Activity Associated with Cortical Arousal in Transgenic PDAPP Mice (hAPP V717F)
Current Alzheimer Research Inhibition of Autophagy Potentiated Hippocampal Cell Death Induced by Endoplasmic Reticulum Stress and its Activation by Trehalose Failed to be Neuroprotective
Current Neurovascular Research Editorial: New Avenues and Therapeutic Strategies for the Treatment of Neurodegenerative Diseases
Current Pharmaceutical Design Cholinesterases and Cholinesterase Inhibitors
Current Enzyme Inhibition Gonadotropin-Releasing Hormone Receptor System: Modulatory Role in Aging and Neurodegeneration
CNS & Neurological Disorders - Drug Targets In Vitro Regulatory Effect of Epididymal Serpin CRES on Protease Activity of Proprotein Convertase PC4/PCSK4
Current Molecular Medicine In Vitro and In Vivo Models of Multiple Sclerosis
CNS & Neurological Disorders - Drug Targets Editorial:Polypharmacology of Natural Products
Mini-Reviews in Organic Chemistry